Stock Analysis
Humana Inc. (HUM) Stock Analysis
Humana Inc. (HUM) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Humana Inc. (HUM) currently has an AIQ Score of 71/100, indicating a bullish setup. Momentum is the strongest factor at 89/100. Quality is the weakest current factor at 50/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
HUM at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $450.00 |
| AIQ Score | 71/100 |
| Overall View | Bullish |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $54.04B |
| P/E Ratio (TTM) | 43.35 |
| Forward P/E | — |
| EPS (Q3 FY2026) | $1.35 |
| Revenue (Q3 FY2026) | $41.16B |
| Dividend Yield (TTM) | 0.79% |
| Beta | 0.54 |
| Volume | 1.5M |
| 52-week range | $163.11-$456.50 |
| RSI 14 | 64.5 |
| 50-Day SMA | $408.68 |
| 200-Day SMA | $317.35 |
| Analyst Price Target | $508.40 |
| Next Earnings | Feb 10, 2027 |
HUMHumana Inc.
Healthcare / Medical - Healthcare Plans
Leader
Strong Relative Position
Latest quote
- Momentum89
- Value76
- Quality50
- Risk resilience67
- Sentiment—
HUM Stock Analysis Summary
Humana Inc. (HUM) currently has an AIQ Score of 71/100, indicating a bullish setup. Momentum is the strongest factor at 89/100. Quality is the weakest current factor at 50/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a bullish regime, HUM has AIQ Score of 71/100 with Momentum base of 89/100 and fading Quality at 50/100. Wait for component alignment before adding exposure.
Momentum (89/100) leads while Quality (50/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 1.42% stock move · HUM classified in Medical - Healthcare Plans.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is HUM Bullish or Bearish Right Now?
HUM currently has a bullish overall setup. Momentum is the strongest factor at 89/100, while Quality is weakest at 50/100. The current evidence suggests a constructive setup.
- - Momentum is constructive at 89/100.
- - Risk Resilience is supportive at 67/100.
- - Price is +10.11% above its 50-day SMA.
- - Analyst target implies +12.98% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (35 vs 8).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
HUM's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 3 neutral, and 8 sell votes. HUM's 14-day RSI is 64.5, which places the stock in a constructive momentum range. HUM's beta is 0.54, indicating lower market sensitivity than the broad market.
What Changed in HUM?
The largest recent change in HUM is Quality moving up by 3.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the HUM Outlook?
The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
HUM Decision Framework
Public evidence layers, setup checks, and risk context for Humana Inc..
Humana Inc. (HUM) Stock Analysis
Humana Inc. has an AIQ Score of 71/100 in a Bullish regime. Momentum is strongest at 89/100. Beta is 0.54, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | HUM is in a Bullish AIQ regime with score 71/100. |
| Signal Conflict | The primary conflict is that momentum leads at 89/100 while quality lags at 50/100. |
| Factor Evidence | Momentum 89/100 · Value 76/100 · Quality 50/100 · Risk 67/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 89/100.
Momentum is 89/100 and RSI (14) is 64.5.
HUM is in a Bullish regime at 71/100.
Risk factor is 67/100 with beta 0.54 and annual volatility 46.03%.
Current conflict: momentum leads at 89/100 while quality lags at 50/100.
HUM Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
HUM Fundamentals
HUM valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
HUM Technical Analysis
HUM technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
HUM Stock Catalysts
Track HUM earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
HUM Dividend Analysis
HUM dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
HUM Financial Data
HUM revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
HUM Risk Analysis
HUM volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
HUM Stock News
HUM stock news, market tone, recent headlines, and catalyst context.
HUM vs Healthcare Services / Managed Care Peers
Current peer cohort: HUM · IQV · LFST · LH · MCK. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| HUM Current stock | 71/100 | 76/100 | 89/100 | 67/100 | 1.55 | 46.03% | Current |
| IQV IQVIA Holdings | 70/100 | 79/100 | 81/100 | 66/100 | 0.53 | 40.72% | HUM vs IQV |
| LFST LifeStance Health | 67/100 | 29/100 | 89/100 | 71/100 | 1.94 | 44.50% | HUM vs LFST |
| LH Labcorp | 73/100 | 81/100 | 79/100 | 83/100 | 1.3 | 24.18% | HUM vs LH |
| MCK McKesson | 76/100 | 77/100 | 91/100 | 82/100 | 0.87 | 31.74% | HUM vs MCK |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
Also for HUM: historical return with reinvested dividends and stock average calculator for several buys.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Nov 16, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching HUM
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for HUM
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
HUM Stock FAQ
What is HUM stock price today?
Humana Inc.'s current stock price is $450.00. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is HUM bullish or bearish right now?
HUM's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is HUM's market cap?
HUM's market cap is $54.04B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is HUM's current P/E ratio?
HUM's current P/E ratio is 43.35 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is HUM's RSI?
HUM's 14-day RSI is 64.5 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is HUM above its 50-day and 200-day moving averages?
HUM is 10.11% from its 50-day SMA and 41.80% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is HUM's next earnings date?
HUM's next earnings date is currently listed as Feb 10, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does HUM pay a dividend?
HUM's dividend yield is 0.79% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.